Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 13/20 | 0.41 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | NQO2 | P16083 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6678542 | 0.78 | NQO2 (0.65) | ARCYP19A1NQO2ALDH1A1HPGD | |
| SCHEMBL6676714 | 0.77 | AR (0.50) | ARCYP19A1NQO2ALDH1A1HPGD | |
| SCHEMBL6682273 | 0.75 | NQO2 (0.44) | ARCYP19A1NQO2ALDH1A1HPGD | |
| SCHEMBL6677200 | 0.75 | AR (0.48) | AR | |
| SCHEMBL24715739 | 0.74 | NQO2 (0.64) | ARCYP19A1NQO2ALDH1A1HPGD | |
| SCHEMBL30275436 | 0.74 | NQO2 (0.64) | ARCYP19A1NQO2ALDH1A1HPGD | |
| SCHEMBL24716655 | 0.70 | NQO2 (0.61) | ARCYP19A1NQO2ALDH1A1HPGD | |
| SCHEMBL30626606 | 0.70 | NQO2 (0.61) | ARCYP19A1NQO2ALDH1A1HPGD | |
| SCHEMBL1770821 | 0.69 | AR (0.70) | ARMAP2K1ALDH1A1HPGDKIF11 | |
| SCHEMBL9388313 | 0.68 | NQO2 (0.43) | ARCYP19A1NQO2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1181341-B1 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | URAY GEORG (AT) | 2004-10-27 | — | — | EP | disclosed |
| US-20020058793-A1 | Luminescent 4-trifluoromethy1-2-quinolones with long wave UV absorption and their use | AGILENT TECHNOLOGIES, INC. | 2002-05-16 | — | — | US | disclosed |
| EP-1181341-A2 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | Uray, Georg (AT) | 2002-02-27 | — | — | EP | disclosed |
| WO-2000066680-A2 | LUMINESCENT 4-TRIFLUOROMETHYL-2-QUINOLONES WITH LONG-WAVE UV-ABSORPTION AND THE USE THEREOF | URAY GEORG (AT) | 2000-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058793-A1 | Luminescent 4-trifluoromethy1-2-quinolones with long wave UV absorption and their use | CYP4F2, CYP4F12, CRY1 | AR 4741/4885MAP2K1 4452/4885CYP19A1 687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.